PIK3CD and acute lymphoblastic leukemia: We observed uniform inhibition of pAkt across all T-ALL cell lines using the pan-PI3K inhibitor PIK-90, the dual PI3K/mTOR inhibitor PI-103, and the mTOR inhibitor INK 128 (Fig 3B–3D).